Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs?-Reference-Cited by-同舟云学术

Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs?

Published:2019-10 Issue: Volume:72 Page:69-76
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

Makarenko Iuliia,Artenie Adelina,Hoj Stine,Minoyan Nanor,Jacka Brendan,Zang Geng,Barlett Gillian,Jutras-Aswad Didier,Martel-Laferriere Valerie,Bruneau Julie

Funder

Canadian Institutes of Health Research

Réseau SIDA et Maladies Infectieuses du Fonds de Recherche du Québec – Santé

Charles LeMoyne Hospital Foundation

Faculty of Medicine and Health Sciences of Université de Sherbrooke

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference74 articles.

1. Eligibility of persons who inject drugs for treatment of hepatitis C virus infection;Arain;World Journal of Gastroenterology,2014

2. Pilot study: Combining formal and peer education with FibroScan to increase HCV screening and treatment in persons who use drugs;Arain;Journal of Substance Abuse Treatment,2016

3. Role of primary care providers in hepatitis C prevention and care: One step away from evidence-based practice;Artenie;Canadian Family Physician Medecin de Famille Canadien,2014

4. Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention;Artenie;The International Journal of Drug Policy,2015

5. Clinicians’ views of hepatitis C virus treatment candidacy with direct-acting antiviral regimens for people who inject drugs;Asher;Substance Use & Misuse,2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individual Heterogeneity and Trends in Hepatitis C Infection Risk Among People Who Inject Drugs: A Longitudinal Analysis;Journal of Viral Hepatitis;2024-09-05

2. Annual trends of hepatitis C virus infection in Manitoba between 1998 and 2018: A focus on special populations;Canadian Liver Journal;2023-07-26

3. HCV treatment initiation in the era of universal direct acting antiviral coverage – Improvements in access and persistent barriers;International Journal of Drug Policy;2023-03

4. Reaching Hard-to-Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis C;Open Forum Infectious Diseases;2022-04-14

5. Client resistance to hepatitis C treatment initiation in opioid agonist treatment clinics in Sydney, Australia: A qualitative study;Drug and Alcohol Review;2021-11-28